» Articles » PMID: 12936706

Mexiletine Carbonyloxy Beta-D-glucuronide: a Novel Metabolite in Human Urine

Overview
Journal Xenobiotica
Publisher Informa Healthcare
Specialties Biochemistry
Toxicology
Date 2003 Aug 26
PMID 12936706
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

1. The study was performed to isolate and characterize a glucuronic acid conjugate of mexiletine that releases mexiletine on acid hydrolysis from urine samples obtained from healthy volunteers following a single oral dose of mexiletine. 2. The [M-H]- ion of the isolated metabolite was observed at m/z 398 in the negative electrospray ionization mass spectrum. This mass number was 44 higher than that of the product generated when mexiletine is subjected to direct glucuronidation. In positive-ion mode, collision-induced dissociation of the quasimolecular ion [M+NH4]+, m/z 417, gave product ions at m/z 224, 180 and 58. These mass spectral data indicated that the metabolite contained a carbonyloxy moiety in its structure in addition to mexiletine and a glucuronic acid moiety. 3. The presence of this carbonyloxy moiety was further supported by the following chemical reactions. When the metabolite was hydrolysed with an aqueous solution of 1 M sodium hydroxide at room temperature, mexiletine was released, whereas the N-methoxycarbonyl derivative of mexiletine was obtained after treatment of the metabolite with methanolic sodium hydroxide solution. 4. The results indicated that the structure of the isolated metabolite was the N-carbonyloxy beta-D-glucuronic acid conjugate of mexiletine.

Citing Articles

Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents.

De Bellis M, De Luca A, Rana F, Cavalluzzi M, Catalano A, Lentini G Br J Pharmacol. 2006; 149(3):300-10.

PMID: 16921388 PMC: 2014276. DOI: 10.1038/sj.bjp.0706867.